Strength
3 mg/1
Manufacturer
Salix Pharmaceuticals Inc.NDC
65649000330
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
9/17/2025
Active Ingredients
PLECANATIDEApproval Type
New Drug (NDA)
FDA Application
NDA208745On Market Since
2/21/2017
Pharmacological Classes
Guanylate Cyclase Activators
Guanylate Cyclase-C Agonist
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.